Delivery Order SPE2DB24D2011-SPE2DB26FBNYB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a ceiling value of $1,130.90. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 23, 2025. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a ceiling value of $14,237.99. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract represents a single delivery order placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $13,839.99. The delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 21, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $4,345.92 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price contract with an ultimate completion date of September 29, 2025, and represents a non-set-aside award issued through competitive procurement. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count packages) under a firm fixed-price contract valued at $6,537.32. This is a competitive, non-set-aside award issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,610.07 to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 17, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a competitive delivery order valued at $1,810.80 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed price contract. The order was placed on September 9, 2025, with an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order as part of its extensive federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on September 8, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $3,223.51. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of September 9, 2025, and is being performed at the contractor's Conshohocken facility. No set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract with a ceiling value of $4,174.60. This non-set-aside competitive award is a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of 180 tablets of Janumet 50-1,000 mg, a combination medication used in diabetes management. This firm fixed-price delivery order, valued at $19,727.92, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026. The award was...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB26FBNYBDelivery Order
The Defense Logistics Agency awarded a $10,383.86 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of October 21, 2025, and performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency, supplying a comprehensive range of pharmaceutical products across multiple therapeutic domains including diabetes medications, neurological treatments, pain management pharmaceuticals, and other specialized medical commodities. This delivery order for Janumet, a common diabetes medication combining metformin and sitagliptin, exemplifies the company's role in supporting Defense Health Agency and military healthcare requirements through the DLA's medical supply chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 10/20/25 |